Alta Partners Management Company, L.P.
SEC exempt reporting adviser (venture capital exemption).
- Website
- HTTP://WWW.ALTAPARTNERS.COM
- HQ
- WY
Alta Partners Management Company, L.P. invests in healthcare through small, focused portfolios, which lets the team keep a high bar and spend more time on each investment. Its listed portfolio companies include biotechnology firms such as Allakos, Ally Therapeutics, and Be Biopharma, plus healthcare services and technology companies such as DispatchHealth, Free Market Health, and Transcarent. Listed leaders include managing directors Dan Janney, Pete Hudson, and Bob More, and CFO Larry Randall.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Growth, Series B, Series A |
| Sectors | Healthtech, Biotech | Not enough dated deals | Biotech, Healthtech, Medical devices |
| Regions | Not stated | Not enough dated deals | CA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 1997 | 1 | Biotech, Healthtech |
| 1999 | 2 | Biotech, Healthtech, Digital health |
| 2000 | 13 | Healthtech, Biotech, Hardware |
| 2001 | 13 | Healthtech, Biotech, Medical devices |
| 2002 | 11 | Biotech, Healthtech, Medical devices |
| 2003 | 13 | Biotech, Healthtech, Digital health |
| 2004 | 23 | Healthtech, Biotech, Medical devices |
| 2005 | 11 | Biotech, Healthtech, Medical devices |
| 2006 | 16 | Healthtech, Biotech, Medical devices |
| 2007 | 37 | Biotech, Healthtech, Medical devices |
| 2008 | 13 | Biotech, Healthtech, Medical devices |
| 2009 | 14 | Biotech, Healthtech, Advanced materials |
| 2010 | 15 | Biotech, Healthtech, Medical devices |
| 2011 | 5 | Healthtech, Biotech, Medical devices |
| 2012 | 6 | Biotech, Healthtech |
| 2013 | 9 | Biotech, Healthtech, Medical devices |
| 2014 | 7 | Biotech, Healthtech, Edtech |
| 2015 | 1 | Biotech |
| 2017 | 6 | Healthtech, Biotech, Life sciences and research tools |
| 2018 | 4 | Biotech, Healthtech, Medical devices |
| 2019 | 3 | Healthtech, Biotech, Life sciences and research tools |
| 2020 | 4 | Biotech, Life sciences and research tools, Healthtech |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2010 | 0 | 0 | 0 | 3 | 9 |
| 2011 | 0 | 0 | 0 | 2 | 1 |
| 2012 | 0 | 0 | 0 | 1 | 4 |
| 2013 | 0 | 0 | 2 | 0 | 5 |
| 2014 | 0 | 0 | 2 | 2 | 3 |
| 2015 | 0 | 0 | 0 | 0 | 1 |
| 2016 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 1 | 2 | 0 |
| 2018 | 0 | 0 | 2 | 0 | 1 |
| 2019 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 0 | 0 | 3 | 0 | 1 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Alta Partners NextGen Fund IV, L.P. Alta Partners invests in healthcare, focusing on life sciences and tech-enabled healthcare services through small, focused portfolios that allow a high bar and more time per investment. The firm says it helps entrepreneurs build high-impact companies. Inferred from the firm's website | approx. 2023 | $250M (Form D) | Open, writing first checks |
| AltaDH Holdings, L.P. | 2021 | $20M to $23.5M (Form D and SEC adviser filing) | Follow-ons only |
| Alta Partners NextGen Fund III, L.P. | approx. 2021 | $250M (Form D) | Follow-ons only |
03 · People across funds
- Daniel Janney, Managing Member of the General Partner of the Issuer
Alta Partners NextGen Fund IV, L.P. (Named on Form D); AltaDH Holdings, L.P. (Named on Form D); Alta Partners NextGen Fund III, L.P. (Named on Form D)
- Bob More, Managing Director
Alta Partners NextGen Fund IV, L.P. (Team); AltaDH Holdings, L.P. (Team); Alta Partners NextGen Fund III, L.P. (Team)
- Dan Janney, Managing Director
Alta Partners NextGen Fund IV, L.P. (Team); AltaDH Holdings, L.P. (Team); Alta Partners NextGen Fund III, L.P. (Team)
- Larry Randall, Chief Financial Officer
Alta Partners NextGen Fund IV, L.P. (Team); AltaDH Holdings, L.P. (Team); Alta Partners NextGen Fund III, L.P. (Team)
- Pete Hudson, Managing Director
Alta Partners NextGen Fund IV, L.P. (Team); AltaDH Holdings, L.P. (Team); Alta Partners NextGen Fund III, L.P. (Team)
- Pete Hudson, M.D., Managing Director
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.ALTAPARTNERS.COM
- https://www.altapartners.com/connect/
- https://www.altapartners.com/team/
- https://www.altapartners.com/portfolio/
- https://www.altapartners.com/about/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026